Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. (HOTH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HOTH · as of Jun 9, 2026
Key Statistics
Explore Hoth Therapeutics, Inc. Data
hoth stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
Competitors & Peers
hoth competitorsHOTH
ASBP
BCTX
CRIS
DARE
ENTOStock Performance
Full HistoryAbout Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, prioritizing the development of novel therapies to address substantial unmet medical requirements. The company is active…
what is hoth therapeutics, inc. · hoth stock overview · hoth therapeutics, inc. company profile · who is hoth therapeutics, inc. ceo · hoth NASDAQ · hoth therapeutics, inc. headquarters · hoth therapeutics, inc. business segments
About Stock Overview & Key Data
Hoth Therapeutics, Inc. (HOTH) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 15, 2019. As of the latest trading session, HOTH stock price is $1.36, with a market capitalization of $18.0M. The stock has returned +14.29% over the past 12 months and +37.37% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Hoth Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Hoth Therapeutics, Inc. reported revenue of — and net income of -$12.5M. For detailed data — including Hoth Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Hoth Therapeutics, Inc. (HOTH) stock price is $1.36. The stock is traded on NASDAQ under the ticker symbol HOTH. The 52-week range is $0.49 – $2.45.